Cormorant Asset Management, LP
46 holdingsFiling period: 2026-03-31Current AUM: $2.15Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | PRAX | PRAXIS PRECISION MEDICINES I | 885.5K | $285.3M | $272.6M | 12.68% | -64,500 | 2026-03-31 |
| 2 | BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 17.88M | $160.0M | $144.6M | 6.73% | -- | 2026-03-31 |
| 3 | EYPT | EYEPOINT INC | 8.27M | $106.5M | $101.2M | 4.71% | -- | 2026-03-31 |
| 4 | EWTX | EDGEWISE THERAPEUTICS INC | 3.26M | $102.7M | $125.3M | 5.83% | -25,000 | 2026-03-31 |
| 5 | ERAS | ERASCA INC | 5.80M | $93.8M | $105.3M | 4.90% | -- | 2026-03-31 |
| 6 | RAPP | RAPPORT THERAPEUTICS INC | 2.96M | $92.5M | $121.2M | 5.64% | -70,000 | 2026-03-31 |
| 7 | ALMS | ALUMIS INC | 3.95M | $87.0M | $111.6M | 5.19% | +313.6K | 2026-03-31 |
| 8 | ABVX | ABIVAX SA | 760.0K | $84.6M | $94.9M | 4.42% | -590,000 | 2026-03-31 |
| 9 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 4.48M | $83.5M | $82.6M | 3.84% | +125.0K | 2026-03-31 |
| 10 | DNTH | DIANTHUS THERAPEUTICS INC | 950.0K | $79.7M | $101.6M | 4.73% | -- | 2026-03-31 |
| 11 | DRUG | BRIGHT MINDS BIOSCIENCES INC | 1.06M | $77.3M | $77.6M | 3.61% | -- | 2026-03-31 |
| 12 | OLMA | OLEMA PHARMACEUTICALS INC | 4.40M | $65.6M | $50.4M | 2.34% | +1.65M | 2026-03-31 |
| 13 | BBIO | BRIDGEBIO PHARMA INC | 850.0K | $63.1M | $68.1M | 3.17% | -350,000 | 2026-03-31 |
| 14 | BIOA | BIOAGE LABS INC | 2.89M | $50.6M | $26.1M | 1.22% | +850.0K | 2026-03-31 |
| 15 | CNTA | CENTESSA PHARMACEUTICALS PLC | 1.05M | $41.7M | $41.7M | 1.94% | -275,000 | 2026-03-31 |
| 16 | DMRA | DAMORA THERAPEUTICS INC | 1.52M | $39.5M | $44.2M | 2.06% | -- | 2026-03-31 |
| 17 | MBX | MBX BIOSCIENCES INC | 1.12M | $33.4M | $73.8M | 3.44% | -- | 2026-03-31 |
| 18 | INSM | INSMED INC | 190.0K | $31.1M | $18.7M | 0.87% | -85,000 | 2026-03-31 |
| 19 | — | NEWAMSTERDAM PHARMA COMPANY | 950.0K | $30.4M | $30.4M | 1.41% | -50,000 | 2026-03-31 |
| 20 | TNGX | TANGO THERAPEUTICS INC | 1.43M | $29.8M | $38.7M | 1.80% | -- | 2026-03-31 |
| 21 | — | PHARVARIS N V | 1.00M | $28.3M | $28.3M | 1.31% | -83,000 | 2026-03-31 |
| 22 | ORKA | ORUKA THERAPEUTICS INC | 533.3K | $26.2M | $51.5M | 2.39% | -- | 2026-03-31 |
| 23 | AGMB | AGOMAB THERAPEUTICS NV | 2.47M | $25.9M | $31.7M | 1.48% | -- | 2026-03-31 |
| 24 | MAZE | MAZE THERAPEUTICS INC | 750.0K | $22.4M | $20.2M | 0.94% | -- | 2026-03-31 |
| 25 | CRBP | CORBUS PHARMACEUTICALS HLDGS | 2.34M | $22.0M | $21.0M | 0.98% | -- | 2026-03-31 |
← Scroll →
Page 1 of 2